申请人:National Center for Geriatrics and Gerontology
公开号:US20180072708A1
公开(公告)日:2018-03-15
An amyloid fibril formation inhibitor comprising a compound represented by the following general formulae (I) to (III):
wherein
Q is —C(═O)—;
X is —C(═O)—, —NH—C(═O)—;
Y is —(CH
2
)
m
—;
Z is —(CH
2
)
n
—;
R
1
, R
2
, and R
3
are each independently a hydrogen atom, an alkyl group, a hydroxyalkyl group, an alkylaminoalkyl group; and
R
4
is an amino group, an alkylamino group or the like;
or a pharmaceutically acceptable salt thereof or a solvate thereof.